nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—PAH—renal system—nephrolithiasis	0.017	0.136	CbGeAlD
Droxidopa—PAH—kidney—nephrolithiasis	0.0165	0.132	CbGeAlD
Droxidopa—DDC—nephron tubule—nephrolithiasis	0.0107	0.0855	CbGeAlD
Droxidopa—DDC—renal system—nephrolithiasis	0.00971	0.0778	CbGeAlD
Droxidopa—DDC—kidney—nephrolithiasis	0.00938	0.0752	CbGeAlD
Droxidopa—DDC—cortex of kidney—nephrolithiasis	0.00914	0.0732	CbGeAlD
Droxidopa—ADRA1B—renal system—nephrolithiasis	0.00765	0.0613	CbGeAlD
Droxidopa—ADRA1B—kidney—nephrolithiasis	0.0074	0.0593	CbGeAlD
Droxidopa—SLC16A10—nephron tubule—nephrolithiasis	0.00732	0.0587	CbGeAlD
Droxidopa—SLC16A10—cortex of kidney—nephrolithiasis	0.00627	0.0502	CbGeAlD
Droxidopa—ADRA2C—nephron tubule—nephrolithiasis	0.00451	0.0361	CbGeAlD
Droxidopa—ADRA1A—renal system—nephrolithiasis	0.0043	0.0344	CbGeAlD
Droxidopa—ADRA2C—renal system—nephrolithiasis	0.0041	0.0328	CbGeAlD
Droxidopa—ADRA2C—kidney—nephrolithiasis	0.00396	0.0317	CbGeAlD
Droxidopa—ADRA2C—cortex of kidney—nephrolithiasis	0.00386	0.0309	CbGeAlD
Droxidopa—SLC6A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00327	0.00374	CbGpPWpGaD
Droxidopa—ADRA2C—Integration of energy metabolism—CHRM3—nephrolithiasis	0.0032	0.00365	CbGpPWpGaD
Droxidopa—ADRA2A—cortex of kidney—nephrolithiasis	0.00308	0.0247	CbGeAlD
Droxidopa—SLC6A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00304	0.00347	CbGpPWpGaD
Droxidopa—SLC6A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00304	0.00347	CbGpPWpGaD
Droxidopa—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00293	0.00335	CbGpPWpGaD
Droxidopa—ADRA1D—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00284	0.00325	CbGpPWpGaD
Droxidopa—ADRB3—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00281	0.00321	CbGpPWpGaD
Droxidopa—SLC16A10—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00279	0.00318	CbGpPWpGaD
Droxidopa—SLC16A10—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00279	0.00318	CbGpPWpGaD
Droxidopa—ADRA2A—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00277	0.00316	CbGpPWpGaD
Droxidopa—ADRB1—G alpha (s) signalling events—PTH—nephrolithiasis	0.00274	0.00314	CbGpPWpGaD
Droxidopa—ADRA1B—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00272	0.00311	CbGpPWpGaD
Droxidopa—SLC6A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00271	0.0031	CbGpPWpGaD
Droxidopa—SLC6A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00269	0.00307	CbGpPWpGaD
Droxidopa—SLC6A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00269	0.00307	CbGpPWpGaD
Droxidopa—ADRB2—G alpha (s) signalling events—PTH—nephrolithiasis	0.00268	0.00307	CbGpPWpGaD
Droxidopa—PAH—Metabolism—GRHPR—nephrolithiasis	0.00266	0.00304	CbGpPWpGaD
Droxidopa—ADRA2A—Integration of energy metabolism—CHRM3—nephrolithiasis	0.0026	0.00297	CbGpPWpGaD
Droxidopa—ADRB1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00259	0.00296	CbGpPWpGaD
Droxidopa—SLC16A10—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00259	0.00296	CbGpPWpGaD
Droxidopa—SLC16A10—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00259	0.00296	CbGpPWpGaD
Droxidopa—ADRA2B—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00259	0.00296	CbGpPWpGaD
Droxidopa—ADRB2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00253	0.0029	CbGpPWpGaD
Droxidopa—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00243	0.00278	CbGpPWpGaD
Droxidopa—ADRA2C—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00242	0.00276	CbGpPWpGaD
Droxidopa—ADRA1A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00242	0.00276	CbGpPWpGaD
Droxidopa—PAH—Disease—SLC26A1—nephrolithiasis	0.00241	0.00275	CbGpPWpGaD
Droxidopa—ADRB3—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00241	0.00275	CbGpPWpGaD
Droxidopa—SLC6A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.0024	0.00274	CbGpPWpGaD
Droxidopa—PAH—Metabolism—AGXT—nephrolithiasis	0.00237	0.00271	CbGpPWpGaD
Droxidopa—ADRA1D—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00237	0.00271	CbGpPWpGaD
Droxidopa—ADRA1B—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00236	0.0027	CbGpPWpGaD
Droxidopa—SLC16A10—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00231	0.00264	CbGpPWpGaD
Droxidopa—SLC16A10—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00231	0.00264	CbGpPWpGaD
Droxidopa—SLC6A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00219	0.00251	CbGpPWpGaD
Droxidopa—SLC6A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00219	0.00251	CbGpPWpGaD
Droxidopa—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00216	0.00247	CbGpPWpGaD
Droxidopa—PAH—Disease—ATP6V0A4—nephrolithiasis	0.00215	0.00245	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—RGS14—nephrolithiasis	0.00212	0.00243	CbGpPWpGaD
Droxidopa—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00212	0.00242	CbGpPWpGaD
Droxidopa—ADRA1A—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.0021	0.0024	CbGpPWpGaD
Droxidopa—PAH—Metabolism—SLC26A1—nephrolithiasis	0.00202	0.00231	CbGpPWpGaD
Droxidopa—PAH—Metabolism—APRT—nephrolithiasis	0.00202	0.00231	CbGpPWpGaD
Droxidopa—ADRA1B—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00197	0.00225	CbGpPWpGaD
Droxidopa—ADRA2A—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00197	0.00225	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—RGS14—nephrolithiasis	0.00193	0.0022	CbGpPWpGaD
Droxidopa—SLC16A10—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00185	0.00211	CbGpPWpGaD
Droxidopa—ADRB3—GPCR ligand binding—CHRM3—nephrolithiasis	0.00184	0.0021	CbGpPWpGaD
Droxidopa—ADRA1D—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00183	0.00209	CbGpPWpGaD
Droxidopa—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00176	0.00201	CbGpPWpGaD
Droxidopa—ADRA1A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00175	0.002	CbGpPWpGaD
Droxidopa—DDC—Metabolism—GRHPR—nephrolithiasis	0.00172	0.00197	CbGpPWpGaD
Droxidopa—ADRB3—GPCR ligand binding—PTH—nephrolithiasis	0.00168	0.00192	CbGpPWpGaD
Droxidopa—ADRB1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00167	0.00191	CbGpPWpGaD
Droxidopa—SLC6A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00166	0.0019	CbGpPWpGaD
Droxidopa—SLC6A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00166	0.0019	CbGpPWpGaD
Droxidopa—ADRA2B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00165	0.00189	CbGpPWpGaD
Droxidopa—ADRB2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00163	0.00187	CbGpPWpGaD
Droxidopa—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00157	0.00179	CbGpPWpGaD
Droxidopa—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00156	0.00179	CbGpPWpGaD
Droxidopa—ADRA2C—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00155	0.00177	CbGpPWpGaD
Droxidopa—SLC6A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00154	0.00177	CbGpPWpGaD
Droxidopa—SLC6A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00154	0.00177	CbGpPWpGaD
Droxidopa—DDC—Metabolism—AGXT—nephrolithiasis	0.00154	0.00175	CbGpPWpGaD
Droxidopa—ADRA1B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00152	0.00174	CbGpPWpGaD
Droxidopa—PAH—Metabolism—AQP1—nephrolithiasis	0.00144	0.00164	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—DGKH—nephrolithiasis	0.00143	0.00164	CbGpPWpGaD
Droxidopa—ADRB1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00143	0.00163	CbGpPWpGaD
Droxidopa—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00142	0.00162	CbGpPWpGaD
Droxidopa—ADRB2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0014	0.0016	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—RGS14—nephrolithiasis	0.00138	0.00158	CbGpPWpGaD
Droxidopa—SLC6A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00138	0.00157	CbGpPWpGaD
Droxidopa—SLC6A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00138	0.00157	CbGpPWpGaD
Droxidopa—ADRA1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00135	0.00154	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—ADCY10—nephrolithiasis	0.00134	0.00153	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—SLC7A9—nephrolithiasis	0.00134	0.00153	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—DGKH—nephrolithiasis	0.00134	0.00153	CbGpPWpGaD
Droxidopa—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00132	0.00151	CbGpPWpGaD
Droxidopa—DDC—Metabolism—SLC26A1—nephrolithiasis	0.00131	0.00149	CbGpPWpGaD
Droxidopa—DDC—Metabolism—APRT—nephrolithiasis	0.00131	0.00149	CbGpPWpGaD
Droxidopa—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0013	0.00149	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—DGKH—nephrolithiasis	0.0013	0.00149	CbGpPWpGaD
Droxidopa—PAH—Metabolism—CHRM3—nephrolithiasis	0.0013	0.00149	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00126	0.00144	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—RGS14—nephrolithiasis	0.00126	0.00144	CbGpPWpGaD
Droxidopa—ADRA2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00126	0.00143	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—RGS14—nephrolithiasis	0.00125	0.00143	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—DGKH—nephrolithiasis	0.00125	0.00142	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—SLC7A9—nephrolithiasis	0.00125	0.00142	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00123	0.00141	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR ligand binding—CHRM3—nephrolithiasis	0.0012	0.00137	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—RGS14—nephrolithiasis	0.00117	0.00133	CbGpPWpGaD
Droxidopa—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00116	0.00132	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—RGS14—nephrolithiasis	0.00115	0.00131	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—RGS14—nephrolithiasis	0.00114	0.00131	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—RGS14—nephrolithiasis	0.00114	0.0013	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—RGS14—nephrolithiasis	0.00113	0.0013	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—RGS14—nephrolithiasis	0.00112	0.00128	CbGpPWpGaD
Droxidopa—SLC6A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.0011	0.00126	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR ligand binding—PTH—nephrolithiasis	0.00109	0.00125	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00109	0.00124	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—CHRM3—nephrolithiasis	0.00108	0.00123	CbGpPWpGaD
Droxidopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00108	0.00123	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—CHRM3—nephrolithiasis	0.00107	0.00122	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—RGS14—nephrolithiasis	0.00106	0.00121	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—RGS14—nephrolithiasis	0.00104	0.00119	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00104	0.00119	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00102	0.00117	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—SLC7A9—nephrolithiasis	0.00101	0.00116	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—DGKH—nephrolithiasis	0.00101	0.00116	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—CHRM3—nephrolithiasis	0.00101	0.00115	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—PTH—nephrolithiasis	0.000996	0.00114	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—CHRM3—nephrolithiasis	0.000992	0.00113	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—PTH—nephrolithiasis	0.000987	0.00113	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—PTH—nephrolithiasis	0.000975	0.00111	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—PTH—nephrolithiasis	0.000949	0.00108	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000948	0.00108	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—CHRM3—nephrolithiasis	0.000942	0.00108	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—DGKH—nephrolithiasis	0.000935	0.00107	CbGpPWpGaD
Droxidopa—DDC—Metabolism—AQP1—nephrolithiasis	0.00093	0.00106	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—RGS14—nephrolithiasis	0.000926	0.00106	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—PTH—nephrolithiasis	0.000922	0.00105	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—PTH—nephrolithiasis	0.000908	0.00104	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000881	0.00101	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—ADCY10—nephrolithiasis	0.000873	0.000997	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—PTH—nephrolithiasis	0.000861	0.000984	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—RGS14—nephrolithiasis	0.000861	0.000983	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000851	0.000973	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—DGKH—nephrolithiasis	0.000849	0.00097	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000844	0.000964	CbGpPWpGaD
Droxidopa—DDC—Metabolism—CHRM3—nephrolithiasis	0.000841	0.000961	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000833	0.000952	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000819	0.000936	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.000806	0.000921	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—ADCY10—nephrolithiasis	0.000795	0.000909	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—DGKH—nephrolithiasis	0.000788	0.000901	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—ADCY10—nephrolithiasis	0.000788	0.0009	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—ADCY10—nephrolithiasis	0.000778	0.000889	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000776	0.000886	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—DGKH—nephrolithiasis	0.000773	0.000884	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00077	0.000879	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—DGKH—nephrolithiasis	0.00077	0.000879	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—DGKH—nephrolithiasis	0.000766	0.000875	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—DGKH—nephrolithiasis	0.000756	0.000864	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—PTH—nephrolithiasis	0.000749	0.000856	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—GRHPR—nephrolithiasis	0.000749	0.000855	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—RGS14—nephrolithiasis	0.000742	0.000848	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—ADCY10—nephrolithiasis	0.000736	0.000841	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—ADCY10—nephrolithiasis	0.000724	0.000828	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—DGKH—nephrolithiasis	0.000716	0.000818	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—DGKH—nephrolithiasis	0.000704	0.000805	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000689	0.000787	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—RGS14—nephrolithiasis	0.000676	0.000773	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000676	0.000772	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—RGS14—nephrolithiasis	0.00067	0.000766	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—AGXT—nephrolithiasis	0.000667	0.000762	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—RGS14—nephrolithiasis	0.000662	0.000756	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	0.000643	0.000735	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00064	0.000731	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—RGS14—nephrolithiasis	0.000626	0.000715	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	0.000626	0.000715	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—PTH—nephrolithiasis	0.000618	0.000706	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—RGS14—nephrolithiasis	0.000616	0.000704	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000616	0.000703	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—CHRM3—nephrolithiasis	0.000614	0.000701	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00061	0.000697	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GRHPR—nephrolithiasis	0.000608	0.000695	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000602	0.000688	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—ADCY10—nephrolithiasis	0.000598	0.000683	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—DGKH—nephrolithiasis	0.000581	0.000664	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00057	0.000651	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—APRT—nephrolithiasis	0.000567	0.000648	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—SLC26A1—nephrolithiasis	0.000567	0.000648	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—PTH—nephrolithiasis	0.000563	0.000643	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—PTH—nephrolithiasis	0.000561	0.000641	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000561	0.000641	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000559	0.000639	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—PTH—nephrolithiasis	0.000558	0.000637	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CHRM3—nephrolithiasis	0.000556	0.000636	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000554	0.000633	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—PTH—nephrolithiasis	0.000551	0.000629	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	0.000547	0.000625	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—CHRM3—nephrolithiasis	0.000547	0.000625	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—AGXT—nephrolithiasis	0.000542	0.000619	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—PTH—nephrolithiasis	0.000521	0.000595	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CHRM3—nephrolithiasis	0.000517	0.000591	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—PTH—nephrolithiasis	0.000513	0.000586	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—PTH—nephrolithiasis	0.000511	0.000584	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000509	0.000582	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—PTH—nephrolithiasis	0.000509	0.000581	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—RGS14—nephrolithiasis	0.000508	0.000581	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—PTH—nephrolithiasis	0.000507	0.000579	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000501	0.000573	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—DGKH—nephrolithiasis	0.000501	0.000573	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—PTH—nephrolithiasis	0.0005	0.000572	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000498	0.000569	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—PTH—nephrolithiasis	0.000473	0.000541	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—PTH—nephrolithiasis	0.000466	0.000532	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000463	0.000529	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—APRT—nephrolithiasis	0.000461	0.000527	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—SLC26A1—nephrolithiasis	0.000461	0.000527	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—DGKH—nephrolithiasis	0.000457	0.000522	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000457	0.000522	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	0.000456	0.000521	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000453	0.000517	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—DGKH—nephrolithiasis	0.000453	0.000517	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000452	0.000517	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000447	0.000511	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—DGKH—nephrolithiasis	0.000447	0.000511	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—PTH—nephrolithiasis	0.000423	0.000484	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—DGKH—nephrolithiasis	0.000423	0.000483	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000423	0.000483	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.00042	0.00048	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—DGKH—nephrolithiasis	0.000416	0.000475	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000416	0.000475	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	0.000414	0.000473	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—AQP1—nephrolithiasis	0.000404	0.000462	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—PTH—nephrolithiasis	0.000384	0.000439	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00037	0.000422	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	0.00037	0.000422	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—CHRM3—nephrolithiasis	0.000366	0.000418	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CHRM3—nephrolithiasis	0.000362	0.000414	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—DGKH—nephrolithiasis	0.000343	0.000392	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000343	0.000392	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—PTH—nephrolithiasis	0.000331	0.000379	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CHRM3—nephrolithiasis	0.00033	0.000377	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—AQP1—nephrolithiasis	0.000328	0.000375	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CHRM3—nephrolithiasis	0.000327	0.000374	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CHRM3—nephrolithiasis	0.000323	0.000369	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CHRM3—nephrolithiasis	0.000306	0.000349	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PTH—nephrolithiasis	0.000302	0.000345	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CHRM3—nephrolithiasis	0.000301	0.000344	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PTH—nephrolithiasis	0.000299	0.000342	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—CHRM3—nephrolithiasis	0.000297	0.000339	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PTH—nephrolithiasis	0.000295	0.000338	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PTH—nephrolithiasis	0.00028	0.000319	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PTH—nephrolithiasis	0.000275	0.000314	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000267	0.000305	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—SPP1—nephrolithiasis	0.000255	0.000292	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000248	0.000284	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	0.000244	0.000279	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PTH—nephrolithiasis	0.000227	0.000259	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—SPP1—nephrolithiasis	0.000166	0.00019	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SPP1—nephrolithiasis	0.000152	0.000173	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SPP1—nephrolithiasis	0.00015	0.000172	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SPP1—nephrolithiasis	0.000148	0.000169	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SPP1—nephrolithiasis	0.00014	0.00016	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SPP1—nephrolithiasis	0.000138	0.000158	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	0.000123	0.00014	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SPP1—nephrolithiasis	0.000114	0.00013	CbGpPWpGaD
